Medtronic - Scientia

Medtronic plc (Medtronic), via its indirect wholly-owned subsidiary Project Saint Merger Sub, Inc., proposes to acquire Scientia Vascular, Inc. (Scientia) (the Acquisition).

Medtronic is a global healthcare technology company incorporated in Ireland and listed on the New York Stock Exchange. Globally (including in Australia), Medtronic develops, manufactures, distributes and sells device-based medical therapies and services within its cardiovascular, neuroscience and medical surgery portfolios. In Australia, Medtronic operates through its Australian subsidiary, Medtronic Australasia Pty Ltd, to supply medical devices, including neurovascular devices such as guidewires, catheters, aspiration catheters, embolic coils, flow diverters, liquid embolic agents, intrasaccular devices, AB stents and stent retrievers. In relation to the supply of guidewires in Australia, Medtronic supplies its Mirage .008” guidewire.

Scientia is a medical device company headquartered in West Valley City, Utah, USA. Scientia specialises in microfabrication technology for guidewires and catheters used in neurovascular and peripheral vascular procedures. In Australia, Scientia supplies guidewires under its “Aristotle” brand through a third-party distributor, LifeHealthcare Pty Ltd. The Aristotle-branded guidewires are supplied in Australia in four diameter configurations, .014”, .018”, .024”, and .035”.

Both Medtronic and Scientia supply neurovascular guidewires in Australia.